Raymond James Financial’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$63.3M Sell
906,016
-835,355
-48% -$62.4M 0.02% 793
2026
Q2
$125M Sell
1,741,371
-1,425,244
-45% -$134M 0.03% 474
2026
Q1
$374M Buy
3,166,615
+2,246,122
+244% +$278M 0.12% 147
2025
Q4
$116M Sell
920,493
-169,975
-16% -$22.2M 0.04% 446
2025
Q3
$160M Sell
1,090,468
-126,057
-10% -$19.1M 0.05% 334
2025
Q2
$190M Sell
1,216,525
-12,281
-1% -$1.95M 0.07% 272
2025
Q1
$202M Buy
1,228,806
+21,840
+2% +$3.63M 0.08% 239
2024
Q4
$197M Buy
+1,206,966
New +$216M 0.07% 239

Other funds holding ZTS

Raymond James Financial's ZTS Position: Q3 2026 in Review

Raymond James Financial reduced its Zoetis (ZTS) stake by 48% in Q3 2026, selling an estimated $62.4M and leaving 906,016 shares worth $63.3M. The position accounts for 0.02% of the portfolio, ranked #793.

Raymond James Financial first reported a position in ZTS in Q4 2024 and has held it in 8 quarters since. The position peaked at $374M in Q1 2026. 1,357 funds tracked by Wall St. Rank hold ZTS as of Q3 2026.

  • Raymond James Financial held 906,016 shares of Zoetis worth $63.3M as of Q3 2026.
  • Raymond James Financial sold 835,355 Zoetis shares in Q3 2026, an estimated $62.4M.
  • Zoetis made up 0.02% of Raymond James Financial's portfolio in Q3 2026, its #793 holding.
  • Raymond James Financial first reported a position in Zoetis in Q4 2024 and has held it in 8 quarters since.
  • Raymond James Financial's Zoetis position peaked at $374M in Q1 2026.
  • 1,357 funds tracked by Wall St. Rank held Zoetis as of Q3 2026.

Based on Raymond James Financial's 13F filing for Q3 2026, filed 12 Nov 2026.